Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference25 articles.
1. Le Tourneau C, Lee JJ, Siu LL. Dose escalation methods in phase I cancer clinical trials. J Natl Cancer Inst. 2009;101(10):708–20.
2. Eisenhauer EA, O’Dwyer PJ, Christian M, Humphrey JS. Phase I clinical trial design in cancer drug development. J Clin Oncol. 2000;18(3):684–92.
3. Optimizing Dosing in Oncology Drug Development. Friends of cancer research 2021. p. https://friendsofcancerresearch.org/sites/default/files/2021-11/Optimizing_Dosing_in_Oncology_Drug_Development.pdf.
4. Administration FaD. Project optimus: reforming the dose optimization and dose selection paradigm in oncology. 2022. 01/31/2022 [cited; Available from: https://www.fda.gov/about-fda/oncology-center-excellence/project-optimus.
5. Shah M, Rahman A, Theoret MR, Pazdur R. The drug-dosing conundrum in oncology—when less is more. N Engl J Med. 2021;385(16):1445–7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献